Senores Pharmaceuticals Q4 Results
- BSE: 544319
- NSE: SENORES
- ISIN: INE0RB801010
- Sector: Biotechnology & Drugs
BSE
1,415.95
-4.90 (-0.34%)
-4.90 (-0.34%)Volume7.36 K
Updated: Fri 10 Jul, 2026 | 07:50:02
NSE
1,417.80-1.90 (-0.13%)
-1.90 (-0.13%)Volume1.95 L
Updated: Fri 10 Jul, 2026 | 15:52:01
Technical Trends
Long TermConsiders price movement over the last 6 months
Not Available
Short TermConsiders price movement over the last 1-2 weeks
Not Available
- Bearish
- Moderately Bearish
- Neutral
- Moderately Bullish
- Bullish
Insight: Trends unavailable at the moment.
Q4 Results Highlights
- Total Income₹175.19 Cr.(53.39%)
- Operating Profit₹38.19 Cr.(168.75%)
- Profit After Tax₹31.61 Cr.(77.29%)
- Operating Margin21.80%(75.21%)
Note: Comparison is on YoY basis
Quarterly - Senores Pharmaceuticals Q4 Results
*All figures in crores except per share values
| Fiscal Period | Mar 26 | Dec 25 | QoQ Comp | Mar 25 | YoY Comp |
|---|---|---|---|---|---|
| Total Operating Expense | 137.00 | 128.42 | 6.68% | 100.00 | 37.00% |
| Depreciation/ Amortization | 9.30 | 7.86 | 18.32% | 5.23 | 77.82% |
| Operating Income | 38.19 | 46.14 | -17.23% | 14.21 | 168.75% |
| Net Income | 31.61 | 31.66 | -0.16% | 17.83 | 77.29% |
| Other Operating Expenses Total | 31.16 | 22.88 | 36.19% | 22.68 | 37.39% |
| Net Income Before Taxes | 47.40 | 44.60 | 6.28% | 20.68 | 129.21% |
| Total Revenue | 175.19 | 174.56 | 0.36% | 114.21 | 53.39% |
| Selling/ General/ Admin Expenses Total | 30.32 | 30.66 | -1.11% | 14.64 | 107.10% |
| Diluted Normalized EPS | 7.96 | 7.29 | 9.19% | 3.98 | 100.08% |
EQUITY QUICK LINKS
FROM MARKETS
Trending Stocks
✕
Wait for it…
Oops! Looks like you have exceeded the limit to bookmark the image. Remove some to bookmark this image.